Option Care Health, INC 8-K filings

Option Care Health announced its second quarter 2026 financial results, reporting increased net revenue, GAAP net income, and diluted EPS, alongside updated full-year guidance.

Option Care Health shareholders re-elected all nine director nominees and ratified the appointment of KPMG LLP as the company's independent auditor.

Option Care Health, Inc. management is participating in the Bank of America Health Care Conference on May 12, 2026, presenting an investor deck.

Option Care Health, Inc. reports the departure of its Chief Growth Officer, Christopher L. Grashoff, effective May 8, 2026, with separation benefits contingent on a general release of claims.

Option Care Health reported mixed first quarter 2026 financial results, with revenue up slightly but Adjusted EBITDA down, leading to an adjustment in full-year revenue guidance.

Option Care Health has entered into a Fifth Amendment to its credit agreement, increasing its revolving credit commitments by $450 million to a total of $850 million.

Option Care Health, Inc. announced strong full-year 2025 revenue growth and positive 2026 financial guidance, despite a slight dip in GAAP net income.

Option Care Health announced strong preliminary Q4 and full-year 2025 results, increased its share repurchase program to $1 billion, and provided positive 2026 financial guidance.

Option Care Health announced robust third-quarter 2025 financial results, driven by a 12.2% increase in net revenue and positive adjusted earnings per share.

Option Care Health, Inc. has amended its First Lien Credit Agreement, refinancing existing term loans at a lower interest rate and extending maturity dates for both term and revolving credit facilities.

Option Care Health announced the appointment of Meenal Sethna as its new Chief Financial Officer, succeeding Michael Shapiro who will transition to an advisory role.

Option Care Health announced its second quarter 2025 financial results, showing robust revenue growth and improved adjusted earnings, but a decline in GAAP net income and a significant drop in cash provided by operating activities.

Option Care Health amends its certificate of incorporation and bylaws following stockholder approval at the 2025 Annual Meeting, enhancing stockholder rights and addressing officer liability.

Option Care Health announces a 16.3% increase in net revenue for Q1 2025, along with updated full-year financial guidance.

Option Care Health announced its Q4 and full-year 2024 financial results, showcasing revenue growth and providing financial guidance for 2025.

Option Care Health reported preliminary unaudited financial results for 2024, exceeding $4.99 billion in revenue, and announced a new $500 million stock repurchase program.

Option Care Health announced a 17% increase in net revenue for Q3 2024, but experienced a decrease in net income and faces supply chain disruptions.

Option Care Health, Inc. announces the resignation of a board member and the adoption of amended bylaws, effective immediately.

Option Care Health's second quarter 2024 results show a significant increase in revenue but a decrease in net income and adjusted EBITDA compared to the same period last year.

Option Care Health's shareholders approved an amended equity incentive plan, elected all director nominees, and ratified the appointment of KPMG as the company's independent auditor at their annual meeting on May 15, 2024.

Option Care Health Inc. has amended its first lien credit agreement, reducing interest rates and securing an additional $50 million in term loans.

Option Care Health announced a 12.8% increase in net revenue for the first quarter of 2024, reaching $1.146 billion, alongside a 14.2% rise in net income.

Option Care Health is experiencing operational and financial disruptions due to a cybersecurity incident at Change Healthcare, impacting claims processing and cash flow.

Option Care Health reported a 9.5% increase in net revenue for the fourth quarter of 2023 and a 9.1% increase for the full year, alongside significant growth in adjusted EBITDA and net income.